DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Alovudine is an investigational drug.
There have been 6 clinical trials for Alovudine. The most recent clinical trial was a Phase 2 trial, which was initiated on February 6th 2018.
The most common disease conditions in clinical trials are HIV Infections, Immunologic Deficiency Syndromes, and Acquired Immunodeficiency Syndrome. The leading clinical trial sponsors are Lederle Laboratories, National Cancer Institute (NCI), and ECOG-ACRIN Cancer Research Group.
Recent Clinical Trials for Alovudine
|Testing Treatment With Encorafenib and Binimetinib Before Surgery for Melanoma With Lymph Node Involvement||National Cancer Institute (NCI)||Phase 2|
|Testing Treatment With Encorafenib and Binimetinib Before Surgery for Melanoma With Lymph Node Involvement||ECOG-ACRIN Cancer Research Group||Phase 2|
|Multi-modality Imaging and Collection of Biospecimen Samples in Understanding Bone Marrow Changes in Patients With Acute Myeloid Leukemia Undergoing TBI and Chemotherapy||National Cancer Institute (NCI)||Phase 2|